Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects - PubMed (original) (raw)
Affiliations
- PMID: 1568535
Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects
R H Eckel et al. Diabetes. 1992 May.
Abstract
Dietary medium-chain triglycerides (MCT) may improve insulin-mediated glucose metabolism. To examine this possibility, 10 non-insulin-dependent diabetes mellitus (NIDDM) patients, 4 hypertriglyceridemic, and 6 normotriglyceridemic nondiabetic control subjects were examined with a 5-day cross-over design, in which the short-term metabolic effects of a 40% fat diet containing 77.5% of fat calories as MCT were compared with an isocaloric long-chain triglyceride-containing diet. In diabetic patients, MCT failed to alter fasting serum glucose concentrations but reduced preprandial glycemic excursions by 45% (F = 7.9, P less than 0.01). On MCT, the amount of glucose needed to maintain euglycemia during an intravenous insulin infusion was increased in diabetic subjects by 30%, in hypertriglyceridemic subjects by 30%, and in normotriglyceridemic control subjects by 17%. MCT increased mean +/- SE insulin-mediated glucose disposal (4.52 +/- 0.56 vs. 2.89 +/- 0.21 mg.kg-1.min-1; n = 3, P less than 0.05) but failed to alter basal glucose metabolism or insulin-mediated suppression of hepatic glucose output. Metabolic responses to MCT were observed independent of sulfonylurea therapy or severity of fasting hyperglycemia. No change in fasting serum insulin or triglyceride concentrations were seen with MCT administration. Although MCT increased mean fasting serum beta-hydroxybutyrate levels from 0.10 +/- 0.03 to 0.26 +/- 0.06 mM (P less than 0.05) in normotriglyceridemic nondiabetic subjects, no change was seen in diabetic patients. Thus, MCT-containing diets increased insulin-mediated glucose metabolism in both diabetic patients and nondiabetic subjects. In diabetic subjects, this effect appears to be mediated by increases in insulin-mediated glucose disposal.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G, De Natale C, Iovine C, Patti L, Di Marino L, Coppola S, Del Prato S, Riccardi G, Rivellese AA. Annuzzi G, et al. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2397-402. doi: 10.1161/01.ATV.0000146267.71816.30. Epub 2004 Sep 30. Arterioscler Thromb Vasc Biol. 2004. PMID: 15458975 - Dietary substitution of medium chain triglycerides in subjects with non-insulin-dependent diabetes mellitus in an ambulatory setting: impact on glycemic control and insulin-mediated glucose metabolism.
Yost TJ, Erskine JM, Gregg TS, Podlecki DL, Brass EP, Eckel RH. Yost TJ, et al. J Am Coll Nutr. 1994 Dec;13(6):615-22. doi: 10.1080/07315724.1994.10718457. J Am Coll Nutr. 1994. PMID: 7706596 Clinical Trial. - Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.
Koopmans SJ, Mroz Z, Dekker R, Corbijn H, Ackermans M, Sauerwein H. Koopmans SJ, et al. Metabolism. 2006 Jul;55(7):960-71. doi: 10.1016/j.metabol.2006.03.004. Metabolism. 2006. PMID: 16784971 - The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction.
Williamson JR, Arrigoni-Martelli E. Williamson JR, et al. Int J Clin Pharmacol Res. 1992;12(5-6):247-52. Int J Clin Pharmacol Res. 1992. PMID: 1301405 Review. - Effects of sucrose on carbohydrate and lipid metabolism in NIDDM patients.
Hollenbeck CB, Coulston AM, Reaven GM. Hollenbeck CB, et al. Diabetes Care. 1989 Jan;12(1):62-6; discussion 81-2. doi: 10.2337/diacare.12.1.62. Diabetes Care. 1989. PMID: 2653750 Review.
Cited by
- Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axis.
Cao Y, Araki M, Nakagawa Y, Deisen L, Lundsgaard A, Kanta JM, Holm S, Johann K, Brings Jacobsen JC, Jähnert M, Schürmann A, Kiens B, Clemmensen C, Shimano H, Fritzen AM, Kleinert M. Cao Y, et al. Mol Metab. 2024 Sep;87:101991. doi: 10.1016/j.molmet.2024.101991. Epub 2024 Jul 15. Mol Metab. 2024. PMID: 39019116 Free PMC article. - Association of Circulating Caprylic Acid with Risk of Mild Cognitive Impairment and Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Cohort.
Fan L, Zhu X, Borenstein AR, Huang X, Shrubsole MJ, Dugan LL, Dai Q. Fan L, et al. J Prev Alzheimers Dis. 2023;10(3):513-522. doi: 10.14283/jpad.2023.37. J Prev Alzheimers Dis. 2023. PMID: 37357292 Free PMC article. - Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.
Kanta JM, Deisen L, Johann K, Holm S, Lundsgaard A, Lund J, Jähnert M, Schürmann A, Clemmensen C, Kiens B, Fritzen AM, Kleinert M. Kanta JM, et al. Mol Metab. 2023 Aug;74:101760. doi: 10.1016/j.molmet.2023.101760. Epub 2023 Jun 24. Mol Metab. 2023. PMID: 37356805 Free PMC article. - Blood Glucose Response of a Low-Carbohydrate Oral Nutritional Supplement with Isomaltulose and Soluble Dietary Fiber in Individuals with Prediabetes: A Randomized, Single-Blind Crossover Trial.
Kokubo E, Morita S, Nagashima H, Oshio K, Iwamoto H, Miyaji K. Kokubo E, et al. Nutrients. 2022 Jun 9;14(12):2386. doi: 10.3390/nu14122386. Nutrients. 2022. PMID: 35745116 Free PMC article. Clinical Trial. - The Glucose-Lowering Effects of Coconut Oil: A Case Report and Review of the Literature.
Malaeb S, Spoke C. Malaeb S, et al. Case Rep Endocrinol. 2020 Dec 27;2020:8841781. doi: 10.1155/2020/8841781. eCollection 2020. Case Rep Endocrinol. 2020. PMID: 33425401 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous